BD Veritor™ Plus System
for Rapid Detection of
SARS-CoV-2 & Flu A+B*
Invest in simplicity with the BD Veritor™ Plus System for COVID-19, Flu A and Flu B with a single sample.
Contact Us
A 3-in-1 antigen assay for COVID-19, Flu A and Flu B.*
Reliable multiplex results in 15 minutes.1
BD Veritor™ Plus System streamlines clinical and patient workflows by detecting three major respiratory illnesses in one test, reducing the need for multiple sample collections. With multiple testing modes and streamlined workflows, the analyzer empowers convenience and efficiency.
BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B* offers proven performance vs PCR
| PPA | NPA | Results in |
SARS-CoV-2 | 86.7% (95% CI, 75.8%-93.1%) | 99.5% (95% CI, 97.4%-99.9%) |
15 minutes
|
Influenza A | 82.7% (95% CI, 74.9%-88.5%) | 97.5% (95% CI, 95.7%-98.5%) | 15 minutes |
Influenza B | 80.7% (95% CI, 70.3%-88.1%) | 98.2% (95% CI, 95.7%-99.3%) | 15 minutes |
SARS-CoV-2, Flu A and Flu B† results in 15 minutes
NPA=negative percent agreement; PPA=positive percent agreement.
Ordering information | Cat no. | Qty |
BD Veritor™ System for SARS-CoV-2 & Flu A+B kit* | 256088 | 30 tests |
BD Veritor™ Plus Analyzer | 256066 | 1 unit |
†A negative result does not rule out COVID-19 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. A negative result should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. For additional information, please refer to the HCP fact sheet.
Get more answers with every sample.
Simplifies the testing process
- May help reduce manual test processing errors with its easy operation and single-button functionality.
Provides results traceability
- Captures or downloads the lot number, patient/ specimen ID, operator ID, and test records using the BD Veritor™ InfoWiFi module Provides result traceability.
Delivers workflow efficiency
Adapts easily to your workflow by offering 2 operational modes:
- Walk Away: Allows staff to perform other duties while the sample incubates.
- Analyze Now: After the recommended incubation time, the analyzer displays the proper results, which can be processed in batches.
Achieves reliable, rapid results
Displays easy-to-read digital results for COVID-19 and Flu A+B* in 15 minutes1 :
- “CoV2: +” for positive; “CoV2: –” for negative.
- “FLU A: +” for positive; “FLU A: –” for negative.
- “FLU B: +” for positive; “FLU B: –” for negative.
Contact a Sales Representative to get your organization’s
diagnostic testing program started today
How It Works
The BD Veritor™ Plus System provides an easy sample-collection process that can be incorporated across a variety of clinical settings.
Step 1: Collect sample
Step 2: Mix the swab with the reagent vial
Step 3: Prepare assay with the sample
Step 4: Run the test
Step 5: Insert the cartridge and read the results
BD Veritor™ Plus System Support & Training
See how BD supports you with tools, education, and training—enabling a streamlined point-of-care experience for those you serve, and confidence in your results.
Professional Care Testing
The BD Veritor™ Plus System enhances point-of-care testing for COVID-19, Flu A+B, COVID-19 & Flu A+B,* RSV and Group A Strep, providing rapid diagnostic testing in a convenient, portable instrument.
1. BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 and Flu A+B. Package insert. 500051910 Becton, Dickinson and Company.
BD Life Sciences, 7 Loveton Circle, Sparks, MD 21152-0999 USA 800-638-8663
BD, the BD Logo, and BD Veritor are trademarks of Becton, Dickinson and Company or its affiliates. © 2026 BD. All rights reserved.
bd.com